Cargando…

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Cai, Chenhui, Zhang, Ying, Hu, Xu, Hu, Wenhui, Yang, Sizhen, Qiu, Hao, Chu, Tongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660070/ https://www.ncbi.nlm.nih.gov/pubmed/34900749 http://dx.doi.org/10.3389/fonc.2021.801970

Ejemplares similares

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2022)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
por: Cai, Chenhui, et al.
Publicado: (2021)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Incidence and Risk Factors for Adjacent Segment Disease After Transforaminal Lumbar Interbody Fusion in Patients with Lumbar Degenerative Diseases
por: Ye, Jiawen, et al.
Publicado: (2021)

Interplay Between Iron Overload and Osteoarthritis: Clinical Significance and Cellular Mechanisms
por: Cai, Chenhui, et al.
Publicado: (2022)

Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

Retrospective Analysis of Sagittal Balance Parameters and Clinical Efficacy After Short-Segment Anterior Cervical Spine Surgery with Different Fusion Devices
por: Wei, Zihan, et al.
Publicado: (2022)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma
por: Deng, Tingting, et al.
Publicado: (2022)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status
por: Liu, Qi, et al.
Publicado: (2023)

Exploration of a Novel Prognostic Nomogram and Diagnostic Biomarkers Based on the Activity Variations of Hallmark Gene Sets in Hepatocellular Carcinoma
por: Zhong, Xiongdong, et al.
Publicado: (2022)

Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
por: Che, Li, et al.
Publicado: (2022)

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2020)

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
por: Wen, Jie, et al.
Publicado: (2022)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment
por: Yu, Jiahao, et al.
Publicado: (2022)

SP70 is a novel biomarker of hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023)

SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Ye, Mu, et al.
Publicado: (2021)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Sun, Wan, et al.
Publicado: (2021)

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
por: Cai, Lin, et al.
Publicado: (2023)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma
por: Váncza, Lóránd, et al.
Publicado: (2023)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021)

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma
por: Xie, Yuwei, et al.
Publicado: (2022)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma
por: He, Ying, et al.
Publicado: (2022)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma
por: Hu, Xiaoshan, et al.
Publicado: (2022)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
por: Zhang, Tao, et al.
Publicado: (2020)

Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jb785r54qsblraliole9j0ab3f